Welcome to the February 2017 edition of our newsletter, Updates on Myeloproliferative Neoplasms. This month I'd like to highlight Chapter 6 of the expert video roundtable I moderated, as it discusses current treatment approaches for MPNs.
You’ll also find links to articles on such topics as the significant effects of high symptom burden in patients with myeloproliferative disorders; how genetic profiling can guide stem cell transplantation for patients with myelodysplastic syndromes; and the significance of the differences in hematologic and clinical features between essential thrombocythemia cases with JAK2- or CALR-mutations.
Please share this newsletter with your colleagues, and don’t hesitate to get in touch with me with your comments or suggestions through the editors of the Journal of the Advanced Practitioner in Oncology, or JADPRO, at email@example.com at any time.
Until next time, take a look at the links I’ve gathered for you here. I hope you find this newsletter to be a useful resource in your practice.
Lindsey Lyle, MS, PA-C
University of Colorado, Anschutz Medical Campus